Results 271 to 280 of about 1,882,229 (349)

T and B cell responses against Epstein-Barr virus in primary sclerosing cholangitis. [PDF]

open access: yesNat Med
ElAbd H   +39 more
europepmc   +1 more source

A seroepidemiological study of cytomegalovirus and Epstein-Barr virus in rheumatoid arthritis and sicca syndrome. [PDF]

open access: bronze, 1985
Patrick J Venables   +5 more
openalex   +1 more source

Use of the QuantiFERON Monitor Assay to Predict Clinical Outcomes in Solid Organ and Hematopoietic Cell Transplant Recipients: A Scoping Review

open access: yesTransplant Infectious Disease, EarlyView.
QuantiFERON‐Monitor (QFM) is an interferon‐gamma release assay that could measure the level of immunosuppression and predict infections in transplant recipients. We reviewed 13 published studies (9 solid organ, 4 hematopoietic cell recipients). Low QFM values were associated with infection in 7/8 studies, and correlations with immunosuppression were ...
Bradley J. Gardiner   +5 more
wiley   +1 more source

Epstein-Barr virus and multiple sclerosis: lesson learned to develop better nonhuman primate models. [PDF]

open access: yesExp Mol Med
Nguyen HD   +6 more
europepmc   +1 more source

Blocking of Acid-fixed Nuclear Binding of Epstein-Barr Virus Nuclear Antigen (EBNA) by Different DNA Species

open access: bronze, 1979
Ivan Hirsch   +4 more
openalex   +1 more source

Current Practice Patterns and Educational Needs of the ESCMID Study Group for Infections in Compromised Hots

open access: yesTransplant Infectious Disease, EarlyView.
The ESGICH survey highlights variability in training and support for Immunocompromised Host Infectious Diseases (ICH‐ID). Respondents expressed strong interest in structured education, research collaboration, and certification, underscoring the need for targeted initiatives to strengthen expertise, improve patient care, and define ICH‐ID as a ...
Maddalena Giannella   +7 more
wiley   +1 more source

Twice Weekly Sulfamethoxazole/Trimethoprim for Pneumocystis jiroveci Pneumonia Prophylaxis in Lung Transplant Recipients

open access: yesTransplant Infectious Disease, EarlyView.
A novel regimen of sulfamethoxazole/trimethoprim single strength one tablet twice weekly for Pneumocystis jiroveci Pneumonia (PJP) prophylaxis in lung transplant patients found no cases of PJP over an 8‐year period and may reduce the incidence of medication discontinuation due to adverse effects. ABSTRACT Background Pneumocystis jiroveci pneumonia (PJP)
Chloe Munroe   +8 more
wiley   +1 more source

COVID19‐Related Onset and Relapses of Juvenile Systemic Lupus Erythematosus‐Like Disease

open access: yes
Journal of Paediatrics and Child Health, EarlyView.
Chiara Cannata   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy